Format

Send to

Choose Destination
Acta Pharmacol Sin. 2015 Jan;36(1):51-61. doi: 10.1038/aps.2014.121. Epub 2014 Dec 15.

The multiple universes of estrogen-related receptor α and γ in metabolic control and related diseases.

Author information

1
Goodman Cancer Research Center, McGill University, Montréal, Québec, H3G 1Y6, Canada.
2
1] Goodman Cancer Research Center, McGill University, Montréal, Québec, H3G 1Y6, Canada [2] Departments of Biochemistry, Medicine and Oncology, McGill University, Montréal, Québec, H3G 1Y6, Canada.

Abstract

The identification of the estrogen-related receptors (ERRs) as the first orphan nuclear receptors ignited a new era in molecular endocrinology, which led to the discovery of new ligand-dependent response systems. Although ERR subfamily members have yet to be associated with a natural ligand, the characterization of these orphan receptors has demonstrated that they occupy a strategic node in the transcriptional control of cellular energy metabolism. In particular, ERRs are required for the response to various environmental challenges that require high energy levels by the organism. As central regulators of energy homeostasis, ERRs may also be implicated in the etiology of metabolic disorders, such as type 2 diabetes and metabolic syndrome. Here, we review the recent evidence that further highlights the role of ERRs in metabolic control, particularly in liver and skeletal muscle, and their likely involvement in metabolic diseases. Consequently, we also explore the promises and pitfalls of ERRs as potential therapeutic targets.

PMID:
25500872
PMCID:
PMC4571319
DOI:
10.1038/aps.2014.121
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center